Alternatives to adWATCH

Streamlined surveillance of diverse data sources, seamlessly integrated with a GVP IX compliant signal management platform, can revolutionize your safety data handling. The Evidex platform offers a ready-to-go, GVP-IX compliant signal management solution that simplifies your operations without the hassle of switching between various services. By modernizing your management processes, you can ensure they are audit-proof and efficient. This automation not only helps meet regulatory standards but also enhances the overall value generated for your organization. With automated signal detection, you can identify safety signals from established sources such as ICSR databases, the FDA's Adverse Event Reporting System (FAERS), VigiBase, and clinical trial data. Furthermore, you can incorporate additional data sources, including claims, electronic health records (EHR), and other unstructured information. By aggregating these diverse data pools, you can significantly improve signaling algorithms, streamline validations and assessments, and accelerate responses to pressing drug safety inquiries. Ultimately, this approach transforms how organizations manage and leverage safety data for better outcomes.

Natively built and operated on the Salesforce platform, QHSE is the fastest growing Enterprise Quality, Health and Safety Management System. Unified QHSE solutions combine EQMS with EHS to help customers of all sizes deliver high quality products and services in a safe and sustainable manner. They reduce risk, inefficiencies, and inefficiencies, while protecting their customers, employees, and brand.

Effectively monitor clinical trials from start to finish with Ennov’s comprehensive Clinical Trial Management software. Each year, clinical trial sponsors search for new ways to improve the efficiency and reduce the costs associated with running their trials. Investigational site efficiency and productivity can be improved by centralizing information, actively monitoring progress, automating schedules, managing finances, and providing accurate reporting and metrics. With the Ennov CTMS, trial sponsors and CROs are able to actively address all aspects of trial management from a single platform: investigator sites, patients, SAEs, deviations, inclusions, visit reports, phone contacts, investigational product management, trial facilities, and finances. Study managers can plan and track their trials in real time to make better decisions faster. With the Ennov CTMS dashboard functionality, study personnel get on-demand analytics to improve quality, control risk, and reduce costs.

PharmaPendium serves as a robust platform that grants users access to a wide array of FDA and EMA drug approval documents, encompassing essential aspects like pharmacokinetics, pharmacodynamics, and safety evaluations. This resource delivers in-depth insights into drug-drug interactions, side effects, and outcomes from clinical studies, thereby empowering stakeholders to make well-informed decisions during the drug development process and when making regulatory submissions. Its rich database aids researchers and healthcare practitioners in assessing both the efficacy and safety of medications, playing a pivotal role in the progression of pharmaceutical research and enhancing patient care. Users can explore historical regulatory submissions and leverage past precedents to better understand and anticipate agency requirements. The interface allows for a seamless transition from tabular data to dynamic charts, graphs, and other visual tools, making it easier to analyze and interpret findings. Additionally, users can search for information related to adverse events (MedDRA), therapeutic targets, drug indications, and endpoints utilizing standardized data. Result pages effectively connect preclinical research with clinical applications, facilitating a comprehensive understanding of the drug development landscape. Overall, this platform not only streamlines the research process but also fosters collaboration and knowledge-sharing among industry professionals.

The Kanteron Platform assimilated a wide array of medical images, digital pathology slides, genomic sequences, and patient information from various modalities, scanners, sequencers, and databases, delivering a comprehensive data toolkit to all teams within hospital networks. It emphasizes pharmacogenomics to avert adverse medication events and facilitates the application of precision medicine at the point of care by integrating data sources on drug-gene interactions that were formerly only accessible in less user-friendly formats, such as tables found in PDF documents. By incorporating major pharmacogenomic databases like PharmGKB, CGI, DGIdb, and OpenTargets, it enables users to customize their queries according to specific gene families, types of interactions, and drug classifications. Additionally, its adaptable AI allows users to select the dataset that best aligns with their specific use case, applying it effectively to pertinent medical images. This robust functionality not only enhances the accuracy of medical insights but also fosters a more personalized approach to patient care.

Veeva Vault Safety is an advanced system designed for the management of individual case safety reports, facilitating the collection, processing, and reporting of adverse events related to both clinical trials and marketed products. This comprehensive platform allows sponsors and contract research organizations (CROs) to handle both global and local adverse events for various categories, including drugs, biologics, vaccines, devices, and combination products. Its integrated gateway connections and established reporting protocols enhance the efficiency of submitting cases to regulatory authorities and sharing information with partners. Additionally, the centralized management of coding dictionaries automates updates for MedDRA, WHODrug, and EDQM on a semi-annual basis. By consolidating pharmacovigilance processes within a single cloud environment, Vault Safety promotes proactive measures in ensuring patient safety. The system also utilizes real-time reports and dashboards, coupled with seamless collaboration, to enhance visibility and ensure compliance regarding adverse event reporting. Ultimately, this innovative solution transforms the approach to safety management in the pharmaceutical industry, fostering a more efficient and effective response to patient safety concerns.

Cloudbyz Safety & Pharmacovigilance Solution, a cloud-based solution, is designed to streamline drug safety and pharmacovigilance for pharmaceutical and life sciences companies. The solution automates the process of collecting data, processing it, analyzing it and reporting it in compliance with global regulations. Cloudbyz provides end-to-end management of the pharmacovigilance lifecycle, including adverse event processing, case management, regulatory reporting, signal detection, and risk management. With Cloudbyz, you can optimize your pharmacovigilance processes, accelerate case processing, and increase the accuracy of your safety data, while minimizing risk and ensuring compliance. The benefits of our solution are listed below- 1. Improved Efficiency with Automation 2. Increased data accuracy 3. Real-time visibility 4. Improved Collaboration 5. Enhanced regulatory compliance

Clinevo's electronic Trial Master File (eTMF) is a user-friendly digital solution for the organization and storage of documents, images, and various digital assets related to clinical trials. This eTMF incorporates an integrated DIA reference model and complies with regulatory standards. Additionally, Clinevo offers the MICC Intake, a web-based platform designed for Medical Information Call Centers (MICC) and Pharmacovigilance (PV) professionals to efficiently log, track, and monitor Product Quality Complaints (PQCs), Medical Inquiries (MIs), and Adverse Events (AEs). Furthermore, Clinevo Safety serves as a comprehensive cloud-based system that ensures ease of use and regulatory compliance throughout the entire Pharmacovigilance process, encompassing PV Intake, Case Processing, Regulatory Submissions/AS2 Gateway, Analytics, and Safety Signals, all within a single platform. Lastly, the Clinevo Website Intake tool can seamlessly integrate with Sponsor or CRO websites, offering consumers and reporters an intuitive web interface for easy access and reporting. This innovative suite of tools enhances the efficiency and effectiveness of clinical trial management and safety reporting.

CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.

ExtraView serves as a comprehensive software solution designed for enterprises, focusing on business process management and global quality management systems, particularly in areas like CAPA, adverse event reporting, food safety, bug tracking, change management, and customer support. Users can choose between pre-built solutions or tailor their own specifications to meet unique needs. It can be deployed as a cloud service or installed on local servers, making it versatile for various operational environments. The platform is user-friendly, allowing for easy configuration while also supporting the implementation of fully validated systems for incident management, CAPA, adverse event reporting, root cause analysis, clinical trial data management, and food safety initiatives. Additionally, it facilitates the establishment of bug-tracking, customer support, requirements management, and other vital issue-tracking systems. A noteworthy aspect is that many users can benefit from a robust, free downloadable version of the software. Furthermore, financial organizations often utilize ExtraView to enhance their systems for auditing, ensuring corporate governance, and managing risks effectively. This adaptability makes it an essential tool for a wide range of industries looking to streamline their workflow processes.

MediGrid features an advanced data ingestion engine that excels in structuring and curating your data while also facilitating its transformation and harmonization. This capability empowers researchers to perform analyses across multiple studies or assess adverse effects observed in various research initiatives. Throughout different stages of your research, having real-time insight into patient safety becomes crucial, particularly for the monitoring of adverse effects (AE) and serious adverse events (SAE) both prior to and following market launch. MediGrid stands ready to assist in monitoring, identifying, and alerting you to these potential safety hazards, ultimately enhancing patient safety and safeguarding your organization's reputation. Furthermore, MediGrid efficiently handles the comprehensive tasks of collecting, classifying, harmonizing, and reporting safety data, allowing you to focus more on your research objectives with confidence. With such robust support, your research team can ensure that patient welfare remains a top priority.

MediaLab's Intelligent Quality Engine (IQE) solution is designed to deliver powerful automation for laboratory non-conforming event management processes. IQE eliminates the need for paper-based, manual investigation and CAPA processes while reducing cost and supporting the quality improvement program. IQE helps your laboratory follow corrective and preventive action standards as outlined by CAP, joint commission, ISO, and other accrediting bodies. You'll benefit from a streamlined approach that supports your regulatory compliance. Start by using our online form templates, or create your own. Allow employees to create events as problems arise. MediaLab will route your event through each phase of the event management lifecycle, from initial event description to risk analysis, closure, and change effectiveness evaluations. Your current processes and forms work beautifully in IQE.

Preventive medicine represents the next frontier in healthcare. Our mission is to assist healthcare providers in identifying and addressing high-risk patients effectively, thereby ensuring patient safety. This proactive approach aims to reduce the incidence of Adverse Drug Reactions (ADRs) within healthcare facilities, where studies show that 5%-10% of hospitalized patients experience ADRs, leading to increased risks, prolonged hospital stays, and financial losses due to denied reimbursements for extra days and procedures. Notably, these adverse events are avoidable. We collaborate with Accountable Care Organizations (ACOs), Health Maintenance Organizations (HMOs), and payers to minimize unnecessary emergency room visits and hospitalizations, particularly focusing on the elderly population, as data indicate that 15%-30% of ER visits for patients aged 65 and older are attributed to ADRs, frequently resulting in hospital admissions. These preventable occurrences highlight the importance of our work. Our approach is founded on advanced scientific principles that integrate multidisciplinary research. Our technology leverages cutting-edge medical research alongside innovative data science, creating a robust platform that leads to improved patient outcomes and enhances overall healthcare efficiency.

Grounded in established medical science and transparent systems biology, DARA enhances clinical decision-making and intervention strategies. Collaborating with healthcare providers and relevant stakeholders, we deliver digital solutions that revolutionize health screening and the management of chronic diseases. Our approach facilitates the digital evolution of care delivery through the automation of clinical workflows and the use of predictive analytics, all aligned with leading clinical guidelines and best practices. By offering actionable health insights through tailored predictions of disease risk and potential adverse events, we empower physicians to better connect with their patients. Additionally, we support pharmaceutical development by uncovering pharmacodynamics within intricate biological systems and discovering innovative therapeutic options. Utilizing predictive analytics on comprehensive patient data allows for personalized precision medicine, particularly in managing cardiometabolic diseases to avert severe patient outcomes. With our tools, healthcare can become more proactive and responsive, ultimately leading to improved patient care and health outcomes.

ClinSoft™, was developed in-house by Innovate Research. There were no third-party acquisitions and integrations. The system is compliant to FDA regulations (21 CFR Part 11, as well as GCP and HIPAA. The system is fully auditable and validated. ClinSoft™, which is easy to use, ensures quick start-ups and close-outs. This saves you precious time and allows you to be certain that any mid-study amendments or updates to protocols will be made promptly. Innovate Research, an Indian contract research company, provides services in clinical research and regulatory affairs. US FDA 21 CFR Part 11 compliant. Electronic Signatures & Records Secure, Role-Based Access. Audit Trail. Easy to use interface for Edit Checks and CRF Set-up. Frameworks that can be reused for item, panel, visit, and page.

GoResearch™ is an advanced and thoroughly validated online platform designed for electronic data capture (EDC), developed by 2KMM specifically for research initiatives like clinical and observational studies as well as patient registries. It boasts a comprehensive suite of features that facilitate these projects across multiple domains, including the customization of data flow and management of Adverse Events procedures, which includes automatic email alerts to safety teams. Additionally, it allows for random assignment to treatment groups via its integrated randomization module, enables data collection through tailored electronic case report forms (eCRF) to align with the specific needs of each study, and supports the integration of ePRO, eSource, and mHealth data through specialized mobile or web applications, as well as a versatile application programming interface (API). This platform ultimately aims to enhance the efficiency and accuracy of data management in research contexts.

Sentria is a cutting-edge platform that utilizes artificial intelligence to manage adverse event cases and conduct post-marketing surveillance. This software solution is user-friendly, highly customizable, and automated, ensuring it meets industry regulations to improve the efficiency, speed, and accuracy of adverse event handling. It supports pharmacovigilance compliance with international ICH guidelines while adhering to local regulatory requirements for the assessment of adverse events. By providing an easy-to-use interface enhanced with pharmacovigilance automation, Sentria minimizes reporting errors through smart alerts and simplifies report processing by employing international coding standards such as MedDRA and ATC/WHO. The platform enhances analytical capabilities through the use of semantic artificial intelligence tailored for pharmacovigilance needs. Notably, Sentria offers features like secure access controlled by user credentials, comprehensive auditable logs to ensure compliance, and a secure encrypted cloud environment for data protection. These functionalities collectively empower organizations to manage adverse events more effectively, contributing to better patient safety outcomes.

VigiLanz Vaccinate offers comprehensive oversight of the entire vaccination journey, facilitating large-scale vaccination efforts while simultaneously addressing COVID-19 risk within organizations. This platform allows healthcare professionals to swiftly register individuals and obtain necessary consent. By automating workflows and eliminating the need for manual data entry, program administrators can work more efficiently. Furthermore, it helps minimize vaccine waste through real-time analytics that align volume needs with scheduling and demand. Users benefit from immediate insights into vaccination and immunity statistics at various levels, including individual, departmental, hospital, and organizational. The system also streamlines data collection for CDC and state compliance, encompassing reports on adverse side effects. In addition, it allows for the pre-registration of vaccine recipients, evaluates workforce readiness, consolidates immunity data from external sources, gathers reports on adverse reactions, and manages consent documentation. Healthcare workers can be expedited through the vaccination process with streamlined forms, while automated reminders ensure timely registration for follow-up doses and the reporting of any adverse events. This holistic approach not only enhances the efficiency of vaccination programs but also fosters a more organized response to immunization needs.

Salesforce Agentforce Life Sciences is a comprehensive CRM platform designed to support the entire life sciences value chain. It connects clinical development, medical affairs, commercial operations, and patient services within a unified and compliant ecosystem. Built on Salesforce’s deeply integrated platform, it ensures regulatory requirements are embedded into workflows. AI-driven agents assist with clinical trial recruitment, participant management, and predictive enrollment analytics. Medical affairs teams can automate inquiry responses and manage scientific knowledge exchange more efficiently. Commercial teams gain a unified view of healthcare professionals to deliver personalized, omnichannel engagement. The platform enhances patient services with automated insurance verification and proactive support programs. Real-time dashboards provide actionable insights across stakeholders and operations. Integration with Data 360, MuleSoft, Tableau, Slack, and Health Cloud expands collaboration and analytics capabilities. Agentforce Life Sciences empowers organizations to accelerate innovation, improve compliance, and drive better health outcomes.

The Multum database, which encompasses drugs, herbal remedies, and nutraceuticals, stands as a premier resource in the industry aimed at promoting safe medication practices and preventing harmful drug interactions. Its software solutions and databases deliver essential drug information, empowering clinicians to recommend appropriate medications with precise dosages while addressing potential interactions effectively. Lexicon Plus serves as a foundational database, offering extensive drug product and disease terminology that seamlessly connects to our clinical systems and external databases. Additionally, the VantageRx Database is designed in a Microsoft Access format, allowing integration into your applications and providing vital clinical information through multiple database tables. Organizations benefit from development interfaces, ensuring that their unique requirements are addressed. By allowing third-party applications to incorporate specialized functionalities into our software through an open and secure platform, we strive to enhance usability and meet diverse client needs. This integration ultimately aims to improve patient safety and healthcare outcomes.

Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.

Fully automated, AI-enabled Medical Coding software to aid your team work faster & smarter. ClinionAI uses Deep Learning NLP models for the automated coding of adverse events and concomitant medication. The AI Medical Coding algorithm was trained using millions of biomedical terms to aid in medical context learning using machine-learning models. The model embeds MedDRA dictionaries. Clinion EDC adverse event terms are matched by the ML Algorithm with MedDRA dictionary terms. Results with associated confidence scores are displayed. The best fit can be chosen by users!

LifeSphere Medical Affairs, a cloud-centric solution created by ArisGlobal, aims to boost efficiency, adherence to regulations, and teamwork among medical affairs teams. It features a consolidated workspace that integrates medical information management with safety and quality assurance systems, promoting comprehensive automation and instantaneous data exchange. This platform simplifies the collection and management of medical inquiries through various channels, automates the handling of product complaints and adverse events, and guarantees adherence to global regulatory standards that are constantly changing. With its sophisticated analytics and reporting capabilities, it delivers valuable insights that enhance data-informed decision-making and lead to better patient outcomes. LifeSphere Medical Affairs is also built to be both scalable and customizable, accommodating the specific requirements of organizations, regardless of their size. Furthermore, it empowers medical teams to operate more effectively in a dynamic regulatory landscape.

TrominoCARE is a versatile, cloud-driven Medical Information Call Center (MICC) software crafted to streamline daily operations within medical information call centers. It encompasses a thorough database that facilitates the management of MICC activities throughout their entire lifecycle, addressing different types of calls such as medical queries, product quality issues, and adverse event reports. With accessibility on mobile devices, tablets, and desktops, TrominoCARE promotes adaptability and quick responses across various platforms. Its primary features include automating processes for all call types, generating Field Alert Reports (FARs) automatically, and providing a customizable client product dictionary along with tailored workflows to meet specific business requirements. Additionally, the platform includes a mobile app that empowers medical sales representatives and field teams to collect and report information without needing an internet connection, while also ensuring seamless integration with safety and MICC systems. This comprehensive approach enhances both efficiency and communication within the medical information landscape.

NewTn's SAFETY is a cutting-edge cloud platform for pharmacovigilance that aims to streamline safety processes and ease compliance for pharmaceutical companies, emerging startups, and contract research organizations. This solution presents a wide array of features, such as scalable cloud infrastructure for enhanced data storage and processing, the ability to reuse data to avoid repetitive entries, real-time alerts and monitoring to swiftly detect adverse reactions, and strong reporting capabilities that aid in creating DSUR and PBRER reports. Specific use cases demonstrate its value in building pharmaceutical safety databases for new companies, offering budget-friendly safety solutions for cost-conscious CROs, improving regulatory adherence for small and medium-sized pharmaceutical firms, and providing thorough safety data analysis and reporting. The platform is distinguished by its user-friendly interface and experience, along with its specialized support for DSUR and PBRER reporting, making it a versatile and customized solution for various stakeholders in the pharmaceutical industry. Moreover, NewTn's SAFETY ensures that all users can effectively navigate the complexities of safety management with confidence and ease.

TheraDoc® offers an immediate overview of the raw data from a hospital's various source systems, alerting clinicians to possible risks while equipping them with essential information to enhance clinical outcomes, decrease expenses, and bolster regulatory compliance. It allows for rapid adjustments to shifts in regulations and reporting, updates to guidelines, and the expanding scope of surveillance. Additionally, it streamlines workflows specifically designed for VA clinical programs, thus minimizing adverse events and clinical errors. Through TheraDoc, case reviews are facilitated, isolation procedures are accurately implemented, cleaning practices are modified, and lab testing becomes more precise. Moreover, the Antimicrobial Stewardship Program, which engages Clinical Pharmacists collaborating closely with providers, has been a significant catalyst for positive changes in clinical practices. This collaborative approach not only fosters better patient care but also encourages ongoing improvements in treatment protocols.

Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.

Ennov's Pharmacovigilance Suite serves as a comprehensive solution for the collection, management, assessment, and reporting of adverse events in both human and veterinary fields, all within a single database framework. It boasts sophisticated tools for signal detection and data analysis, reinforcing adherence to international regulatory standards. Notable features encompass streamlined case intake and triage processes, enhanced user interfaces for data entry, adaptable case input forms, and an extensive range of searchable vocabulary lists. The system accommodates various reporting formats, including both paper and electronic submissions, compatible with CIOMS guidelines, MedWatch 3500s, and ICH E2B standards (R2 and R3). In terms of signal detection and management, it offers extensive data querying options, robust analytical tools, and the ability to compute essential statistical measures such as PRR, ROR, and MGPS. Entirely web-based and user-friendly, the platform is built to meet the standards of 21 CFR Part 11, thereby guaranteeing the integrity and security of data. Moreover, its adaptability makes it suitable for organizations of all sizes, ensuring that users can efficiently navigate the complexities of pharmacovigilance.

Approximately two-thirds of data from the largest medication history database in the country lacks crucial sig details, potentially putting patients at a heightened risk of adverse drug reactions or worse outcomes. Fortunately, this issue can be addressed. DrFirst's SmartSigSM effectively bridges the information voids caused by absent sig data in a rapid, efficient, and precise manner. Utilizing advanced predictive data provided by SmartStrings, which identifies the most frequently prescribed drugs, SmartSig adeptly converts free text information and can even infer missing elements safely by leveraging statistics and clinical analytics for instant translation at the click of a button. This vital interoperability solution is designed for quick implementation, taking less than two hours, and works seamlessly with major electronic health records, allowing healthcare providers to dedicate more time to their patients while enhancing overall patient safety through proven methods. By streamlining the medication management process, SmartSig not only improves communication but also fosters better health outcomes.

Introducing a cutting-edge AI-driven platform for adverse media research that significantly enhances Anti-Money Laundering (AML) and Know Your Customer (KYC) investigations. Merlon employs a sophisticated natural language processing engine that efficiently extracts and organizes risk-related topics in alignment with both FATF recommendations and the controls required by financial institutions. It also captures essential biographical details for accurate matching with client information. By clustering articles into distinct events, the system reduces the overall volume of articles that analysts need to review. Furthermore, it intelligently identifies and eliminates duplicate content, which greatly shortens the time required for investigations. The results are prioritized based on their AML risk relevance, allowing analysts to detect potential risks more swiftly. Additionally, our natural language processing algorithms uncover risk factors that traditional methods might overlook. To streamline the process further, irrelevant articles are filtered out, ensuring that analysts focus solely on material content that contributes to their investigations. This comprehensive approach not only saves valuable time but also enhances the overall effectiveness of compliance efforts.

QAPI360 is a comprehensive, cloud-based software solution designed for Quality Assurance Performance Improvement (QAPI) that complies with HIPAA regulations, enabling healthcare providers to centralize, organize, and monitor all aspects of their quality programs. By moving away from outdated spreadsheets and disjointed methods, agencies can adopt a systematic, data-driven framework that includes well-structured QAPI plans, quality metrics, and tracking for incidents involving patients and staff. The software also features infection control monitoring, logs for medication errors and adverse drug reactions, hand hygiene initiatives, templates for performance improvement projects, patient satisfaction assessments, and tracking of contracted provider performance, all displayed through interactive dashboards that allow users to identify trends, implement corrective measures, and evaluate results effectively. Additionally, QAPI360 simplifies data entry, supports EMR integration or automated data imports, and provides built-in reporting tools, which facilitate compliance documentation and audits while enhancing the efficiency of data collection, charting, and root-cause analysis processes. Ultimately, this software serves as a vital resource for healthcare agencies striving to enhance their quality assurance initiatives and ensure optimal patient care.

A web-based software suite for medical device companies that automates their processes and simplifies regulatory compliance. Modules include Audit Management, CAPA and Complaint Handling. Designed from the start for ISO 13485 compliance and 21 CFR Part 11 compliance.

SAMS™, the next-generation integrated screening solution, is designed to meet all your Sanctions, PEP and Adverse Media Screening requirements. Our proprietary database contains 600+ global/regional sanctions and watchlists, 5,000,000+ PEP entries and Adverse Media, from more than 55,000 sources in 50+ different languages. It is updated in real-time. It is also flexible enough to add 3rd party databases or internal databases. SAMS™, powered by intuitive workflows created by leading industry experts, automates the initial customer screening process and ongoing monitoring processes. It is designed with robust controls, a complete audit track for regulatory reporting and powerful visualization tools to aid in decision-making.

For nearly 20 years, AB Cube has been a trusted partner in safety management, delivering not just innovative technology, but transparent, compliant solutions designed to scale with your needs and grow alongside your organization.

InSilicoTrials.com is an online platform that offers a user-friendly environment for computational modeling and simulation, featuring a range of integrated, easy-to-navigate in silico tools. It primarily serves professionals in the medical device and pharmaceutical industries. The in silico tools designed for medical devices facilitate computational testing across various biomedical fields, including radiology, orthopedics, and cardiovascular health, during the stages of product design, development, and validation. For the pharmaceutical industry, the platform grants access to in silico tools that support all phases of drug discovery and development across diverse therapeutic areas. We have developed a unique cloud-based platform grounded in crowdscience principles, allowing users to efficiently utilize validated models and reduce their R&D expenses. Additionally, users can explore a continuously expanding catalog of models available for use on a pay-per-use basis, ensuring flexibility and accessibility for their research needs.

cubeSAFETY is an advanced pharmacovigilance platform designed to assist safety teams in efficiently managing adverse-event reporting, regulatory submissions, and case processing in a compliant manner. It adheres to ICH E2B and various regional reporting standards, facilitating submissions to agencies like the FDA, EMA, CDE, MFDS, and PMDA through specialized gateways, while also automatically converting and formatting data for CIOMS and XML export. The platform boasts AI-driven medical coding suggestions, duplication detection, the capability to import CIOMS PDF files, and dynamic dashboards for real-time submission tracking. Additionally, it offers complete integration with other CRScube modules, including cubeCDMS. cubeSAFETY is crafted to enhance the safety-case entry process, guarantee superior data quality through embedded validation features, and streamline workflows for compliance with global regulatory requirements, all while decreasing manual labor and financial overhead. Ultimately, this innovative platform aims to redefine pharmacovigilance efficiency and accuracy across the industry.

BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.

In recent years, the Life Sciences sector has incurred nearly $15 billion in fines and settlements related to compliance, underscoring the importance for firms to follow best practices in pharmaceuticals, medical devices, and biotechnology. Additionally, the way clinical trials are managed can greatly influence the timeline, scope, and financial resources allocated for the development of drugs or medical devices. Utilizing OpenText™ Clinical Trial Quality Management System (ctQMS) allows organizations to maintain compliance, lower record management expenses, and foster collaboration to implement best practices throughout the entire clinical trial lifecycle. This strategic approach not only enhances operational efficiency but also contributes to the overall success of product development initiatives.

Ripjar is a sophisticated platform that leverages artificial intelligence to provide risk and compliance intelligence for various entities, including businesses, financial organizations, government bodies, and security teams, enabling them to effectively identify, track, and analyze threats and risks associated with individuals, organizations, and data on a large scale. By utilizing cutting-edge machine learning, natural language processing, and advanced entity resolution techniques, Ripjar integrates and evaluates both structured and unstructured data from various sources such as sanctions and watchlists, adverse media, internal documents, transactions, and other third-party information, resulting in dynamic risk profiles that refresh in real time, thereby greatly minimizing both false positives and negatives in comparison to conventional screening methods. Among its offerings are solutions for AML name screening and monitoring, which merge diverse compliance results into a cohesive overview; adverse media screening that uncovers hidden and reputational risk indicators; and third-party risk management that consistently evaluates compliance, ethical, prudential, and supply chain risks, ensuring a comprehensive approach to risk assessment. Additionally, Ripjar's platform is designed to adapt to evolving threats, maintaining its effectiveness in a landscape of increasing complexity and regulatory demands.

You face countless decisions that influence how resources are distributed for the efficient management of your utility. The impact of either outdated or incorrect information can negatively affect the choices you make. Our Financial Management System (FMS) is specifically crafted for utilities, providing workflows that are customized for our industry. The features available to your accounting team make FMS an essential resource for ensuring financials are accurately aligned with requirements. This system is designed to process data, categorize it correctly, and produce the necessary reports for stakeholders. By leveraging this technology, you can enhance decision-making and improve overall operational effectiveness.

Automate the identification and resolution of problems in your organization and supply chain. This is one of the most trusted CAPA software applications. It has been trusted by thousands of users worldwide. CAPA Manager corrective actions software automates the assignment of corrective actions, notification, investigation and reporting. It prevents errors in the control of the entire CAPA process from initiation through investigation and closure. CAPA Manager meets all requirements of the most important quality management standards, including ISO 9001, AS9100 and TS 16949. It maintains records of root-cause and corrective actions, and provides pre-defined workflows with approval gates.

SimpleTrials is a subscription-driven, on-demand Clinical Trial Management System (CTMS) tailored for sponsors, Contract Research Organizations (CROs), and research sites. It encompasses a wide array of tools designed to efficiently plan, oversee, and monitor clinical study portfolios, featuring capabilities such as site initiation and subject monitoring, document management through an integrated electronic Trial Master File (eTMF), real-time analytics for studies, comprehensive calendars and monitoring options, customizable fields and trackers, on-demand reporting, planning milestones, management of site contracts and payments, as well as electronic visit documentation. The platform is built to ensure compliance with 21 CFR Part 11 and establishes a secure, validated space for handling clinical trial data. Users benefit from the ability to personalize tracking views, connect with various Electronic Data Capture (EDC) systems, and access pre-built templates for uniform document management. Furthermore, the system enhances collaboration among stakeholders, facilitating smoother communication throughout the trial process.

Folio3 Digital Health offers an all-encompassing Clinical Trial Management Software (CTMS) that is a web-based solution aimed at enhancing the efficiency of the entire clinical trial lifecycle for pharmaceutical firms, contract research organizations (CROs), and research institutions. This platform consolidates various trial operations, facilitating everything from planning and site oversight to data gathering and reporting, while ensuring adherence to international regulations such as FDA 21 CFR Part 11, GxP, and HIPAA. With a focus on delivering user-friendly interface designs, real-time dashboards, and adaptable modules, the software is capable of managing clinical trials of any scale effectively. The system includes specialized modules for study initiation, allowing users to outline protocols, timelines, and budgets using customizable templates tailored to their needs. Moreover, the site management features enable tracking of investigator credentials, contracts, and financial transactions, in addition to patient recruitment tools that streamline screening, monitoring of enrollment, and scheduling of visits, complete with automated reminders to enhance participant engagement. Notably, the platform’s versatility makes it suitable for various stakeholders involved in clinical research, thereby promoting a more integrated and efficient trial management experience.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.